Stock screenerAll disclosures →
EDGAR →
AZN
Conviction 47HealthcareScan · Tue, Sep 8, 2026AZN$160.01-1.65%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 3.39M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price160.01
Change-1.65%
Gap+0.53%
Rel volume2.01×
Avg volume3.4M
Avg $ vol550.9M
SMA 20162.35
SMA 50168.53
SMA 200161.23
Price vs 50-5.06%
Price vs 200-0.76%
MA stackmixed
50/200 cross—
Supertrendup · 157.20
RSI (14)42
MACD hist0.19
MACD cross—
Stoch %K / %D6 / 34
ADX (14)15
+DI / −DI19 / 27
RSI divergence—
MACD divergence—
ATR %+2.33%
ADR %1.71%
52w high209.48
52w low73.53
From 52w high-23.62%
Above 52w low+117.61%
New 52w highNo
SqueezeOff
Bollinger width8.76%
%B0.34
Donchian pos35.02%
Donchian high170.18
Donchian low154.53
AVWAP (52w high)178.44
vs AVWAP high-10.33%
AVWAP (52w low)126.44
vs AVWAP low+26.55%
OBV trendDown
Chaikin MF (20)0.06
Today vs 20d2.01×
Avg vol (14d)3.39M
Avg vol (20d)3.4M
Avg $ vol (20d)550.9M
Market cap277.22B
RS 3m (vs SPY)-16.93%
RS 6m (vs SPY)-30.78%
RS line new highNo
Trend template4/8
Technical rank27.4
1 week-1.31%
1 month-0.87%
3 months-11.86%
6 months-17.92%
1 year+95.85%
YTD+74.74%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target219.44
Target upside37.14%
Analyst ratingBuy
Institutional53.29%
Ent. value—
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryDrug Manufacturers - General
ExchangeNYSE
Shares out—
Employees96.1K
ListedFri, Oct 23, 2009
Free float1.54B
Float %99.5%
Short interest1.89M
Days to cover0.3d
Short volume35.2%
Squeeze score17 / 100
Next earnings—
EPS forecast—
Last EPS vs est$2.63 vs $2.50
Last surprise+5.2% beat
Setup gradeC
Conviction47 / 100
Pattern quality—
Tech rank27.4 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance172.96
Support153.97
Days since event—
Candle confirm—
News sentiment—
Congress activity
Disclosed STOCK Act trades in AZN · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Alan Armstrong senate · R · OK · traded 2026-03-31 | Buy | $1K–$15K | 2026-03-31 | 2026-07-21 | |
Alan Armstrong senate · R · OK · traded 2026-03-30 | Buy | $15K–$50K | 2026-03-30 | 2026-07-21 | |
Julia Letlow house · LA · traded 2025-12-08 | Buy | $1K–$15K | 2025-12-08 | 2026-01-01 | |
Gilbert Cisneros house · CA · traded 2025-11-19 | Buy | $1K–$15K | 2025-11-19 | 2025-12-12 | |
Lisa McClain house · MI · traded 2025-10-30 | Buy | $1K–$15K | 2025-10-30 | 2025-11-01 | |
Valerie Hoyle house · D · OR · traded 2025-09-23 | Sell | $1K–$15K | 2025-09-23 | 2025-10-10 | |
Valerie Hoyle house · D · OR · traded 2024-10-29 | Buy | $1K–$15K | 2024-10-29 | 2025-09-12 | |
Lisa McClain house · R · MI · traded 2025-06-17 | Sell | $1K–$15K | 2025-06-17 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-09 | Buy | $1K–$15K | 2025-06-09 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-07-22 | Buy | $1K–$15K | 2025-07-22 | 2025-08-13 |
Insider activity
SEC Form 4 transactions in AZN · 5 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Sharma Mani SVP, Group Controller · Ordinary Shares · 2026-08-06 | Grant | 2 | $327 | 2026-08-06 | 2026-08-07 |
Sharma Mani See Remarks · Ordinary Shares · 2026-07-06 | Grant | 2 | $381 | 2026-07-06 | 2026-07-08 |
Sharma Mani See Remarks · Ordinary Shares · 2026-06-08 | Grant | 1 | $180 | 2026-06-08 | 2026-06-16 |
Sharma Mani See Remarks · Ordinary Shares · 2026-05-20 | Sell | 11.89K | $2.2M | 2026-05-20 | 2026-05-22 |
Sharma Mani See Remarks · Ordinary Shares · 2026-05-06 | Grant | 1 | $186 | 2026-05-06 | 2026-05-08 |
Sharma Mani See Remarks · Ordinary Shares · 2026-04-07 | Grant | 1 | $196 | 2026-04-07 | 2026-05-08 |
SEC filings
EDGAR filings in AZN · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.